Anzeige
Mehr »
Login
Donnerstag, 14.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Kolumbiens nächster Kupferriese? Warum Investoren dieses 14.000-Meter-Bohrprogramm beobachten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
178 Leser
Artikel bewerten:
(1)

Executive search firm Chaberton Partners invests in Ganci Partners to create market leader in Switzerland

Finanznachrichten News

DJ Executive search firm Chaberton Partners invests in Ganci Partners to create market leader in Switzerland

Lemongrass Communications AG / Key word(s): Mergers & Acquisitions/Investment 
Executive search firm Chaberton Partners invests in Ganci Partners to create market leader in Switzerland 
2024-11-12 / 10:00 CET/CEST 
=---------------------------------------------------------------------------------------------------------------------- 
Executive search firm Chaberton Partners invests in Ganci Partners 
to create market leader in Switzerland 
Highlights 
 . Chaberton Partners invests a majority stake in Ganci Partners 
 . The strategic move creates one of the top 3 executive search firms in Switzerland 
 . The deal fosters the undisputable #1 executive search firm in French-speaking Switzerland 
 . The combined firm doubles its size in executive search in Europe 
 . The portfolio includes leading executive assessment centre Novelia 
 . Company plans to accelerate growth in core European markets. 
Lugano/Lausanne, 12 November 2024 - Chaberton Partners, one of Europe's leading executive search firms and rooted in 
Switzerland, today announced that it has invested a majority stake in Ganci Partners, a leading board, executive search 
and assessment firm based in Lausanne, Bern and Geneva. This strategic combination will create one of the top 3 
executive search player in Switzerland and strengthen its market leadership in the French-speaking part of the country. 
The combined business will operate from 12 cities across Europe - in Italy, France, Switzerland and Austria. 
 
Chaberton Partners with Ganci Partners together will create one of the top 3 executive search firms in Switzerland and 
strengthen its market leadership in the French-speaking part of the country. Ganci Partners brings its well-established 
leadership in board and executive search across Switzerland, with 18 consultants in 3 offices, and its own assessment 
centre Novelia, with 5 consultants. Chaberton Partners, a firm 100% owned by its partners and directors, brings a 
strong growth trajectory in the businesses of board advisory, executive and management search in 4 core European 
markets (Italy, Switzerland, France and Austria). 
Vincenzo Ganci, Founder, who will continue to serve as Co-CEO of Ganci Partners with Claire Brizzi, commented: 
"Christian Vasino and I share a vision to build the leading executive search firm in Switzerland and beyond. The 
combination of our firms creates unprecedented opportunities for our clients, candidates and consultants. The 
complementary strengths of Ganci Partners and Chaberton Partners put us in a unique position to help organisations 
identify and assess exceptional leadership talent throughout Switzerland and neighboring countries at the board, 
executive and also at management level". 
"This move represents the next transformative step in our growth journey. I am delighted to welcome Vincenzo Ganci, 
Claire Brizzi and the whole team to Chaberton Partners and believe that together we can take the combined company to 
the next level," said Christian Vasino, founder and CEO of Chaberton Partners. "By joining forces with Ganci Partners, 
we will achieve a leading market position in executive search in Switzerland and create a platform that will allow us 
to accelerate our international expansion with a priority focus on France and entering Germany. Our combined expertise 
and shared values will strengthen the service we provide to our clients and candidates in an ever-changing business 
landscape". Vincenzo Ganci will join the leadership team of Chaberton Partners. 
 
The resulting platform will significantly increase its board advisory and executive search market reach, with plans to 
expand further into German-speaking Switzerland and neighboring countries, particularly France and Germany. It will 
leverage its expanded footprint to serve a broader client base across 12 cities and provide enhanced career 
opportunities for its growing team of partners and consultants. 
The transaction is effective immediately, with both companies maintaining their current operations and brand for the 
time being, while working to integrate their systems, processes and assessment capabilities to better serve their 
clients and candidates. Details of the transaction are not being disclosed. Vincenzo Ganci will join the leadership 
team at Chaberton Partners. 
 
About Chaberton Partners 
Chaberton Partners is a leading European executive search and board advisory firm, established in Lugano in 2017, 
committed to help organisations secure the leadership they need to excel in an ever-evolving global marketplace. In a 
few years the firm has recorded significant growth in Europe opening in 10 cities (Lugano, Geneva, Zurich, Milan, Rome, 
Padua, Paris and Vienna) and has ambitious plans for further expansion. Chaberton Partners combines the sophistication 
of an international firm with the personalized approach of the boutique, and it is fully owned by its partners. 
Chaberton Partners specialises in advising in sectors such as consumer goods, financial and professional services, life 
science, industrial and technology. Its team of partners and consultants combines deep industry insight with a 
commitment to excellence, providing clients with strategic talent acquisition, leadership consulting and organisational 
development services. 
 
About Ganci Partners 
Ganci Partners is a boutique executive search firm, active across Switzerland since 2012, that specialises in 
identifying and placing high-impact executive leaders across a range of industries. With a deep commitment to 
understanding the unique needs of each client, Ganci Partners provides tailored board, executive search, executive 
assessment and strategic talent advisory solutions to ensure organisations find the right leaders to drive durable 
growth and innovation. Leveraging extensive industry expertise and a rigorous approach to candidate assessment, Ganci 
Partners provides a personalised, qualitative, results-driven service that drives long-term success for both clients 
and candidates. Ganci Partners comprises 18 consultants and 5 executive assessors in Novelia across three offices in 
Switzerland (Bern, Geneva and Lausanne). 
 
Media Contact: 
Micol Scabbia, 
Group CMO, Chaberton Partners 
+39 348 8873460 | micol.scabbia@chabertonpartners.com 
 
 

-----------------------------------------------------------------------------------------------------------------------

Additional features: File: PressRelease_FINAL_ENG File: Christian Vasino File: Vincenzo Ganci

-----------------------------------------------------------------------------------------------------------------------

End of Media Release

-----------------------------------------------------------------------------------------------------------------------

2027309 2024-11-12 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2027309&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face

(END) Dow Jones Newswires

November 12, 2024 04:02 ET (09:02 GMT)

© 2024 Dow Jones News
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.